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INTRODUCTION
 Chronic renal failure is a clinical syndrome due to irreversible renal dysfunction 
leading  to  excretory,  metabolic  failure  culminating  in  accumulation  of  non  protein 
nitrogenous substances and present with clinical manifestations.
           Despite various etiologies, CRF is the final common pathway of irreversible 
destruction of  nephrons ultimately  resulting in  alteration of  all  systems in the body. 
Kidney  is  closely  related  to  thyroid  in  the  fact  that  it  is  the  only  other  organ  that 
competes with iodide clearance.
            Patients with CRF have many signs and symptoms suggestive of thyroid 
dysfunction  like  shallow  complexion,  edema,  dry  skin,  cold  intolerance,  decreased 
BMR, asthenia and hyporeflexia. So in cases of CRF, it is difficult to exclude thyroid 
dysfunction on mere clinical background. 
                 Various studies have been conducted on thyroid function in CRF patients,  
since the beginning, the results were inconsistent. Hyperthyroidism, hypothyroidism and 
euthyroidism all  have  been  reported.  The  relation  between  thyroid  dysfunction  and 
severity of CRF is not clear. Several studies depict conflicting results both positive and 
negative.
Prevalence  of  hypothyroidism in  end stage  renal  disease  have  been  estimated 
between 0 and 9%. There is also increased prevalence of goiter in patients with ESRD.
In view of variability of thyroid function test in patients with CRF in previous 
studies,  a  prospective  clinical   and  biochemical  study  on  thyroid  function  in  CRF 
patients in Department of Nephrology, Coimbatore medical college hospital, Coimbatore 
has been taken.
AIM OF THE STUDY
1. To study the prevalence of thyroid hormone dysfunction in patients with  chronic 
renal failure. 
2. To study the correlation between thyroid hormone dysfunction and severity of renal 
diseases.
3.  To differentiate primary  thyroid diseases from thyroid dysfunction due to chronic 
renal failure.
REVIEW OF LITERATURE
1. PHYSIOLOGY OF THYROID HORMONES
Thyroxine (T4) and Triiodothyronine (T3) are the principle hormones produced  by 
thyroid gland.
Initially iodine is absorbed in the gut and converted to iodide and transported in 
the blood.  It is then actively transferred into the thyroid cell by “Iodide trapping”.  The 
trapped iodide  is  “Oxidized”   to  iodine  and combines  with  tyrosine  to  form Mono 
iodotyrosine (MIT) and Diiodotyrosine (DIT).  MIT and DIT are coupled to form T 3 
whereas two DIT coupled to form T4.  Oxidation, Iodination and coupling reactions are 
catalyzed by “Thyroid peroxidase”.  Thyroid hormone thus produced are bound with 
thyroglobulin until secreted. (Pic.1)
It is  secreted in the blood and transported in two forms.  One is bound form, in 
which  T3  and  T4 are  bound  to  plasma  proteins  namely  thyroid  binding  globulin, 
prealbumin and albumin. T4 is predominantly bound to thyroid binding globulin whereas 
T3 is predominantly bound to albumin.  The other form is free T3 and T4.  These free 
forms are in equilibrium with bound form.
In the periphery one third of T4 is converted to T3 by 5’ Deiodenase and 45% to 
rT3 by  5 deiodenase.  They are further metabolized to Diiodothyronines.  Only about 
13% of T3 is produced from thyroid gland and remaining 87% is formed from T4. 
Control of thyroid hormones
The thyroid stimulating hormone (TSH) controls the secretion of T3 and T4.  It is 
secreted in pulsatile manner with peak secretion at night by anterior pituitary.  TSH 
secretion is stimulated by thyrotropin releasing hormone (TRH) which is secreted by 
hypothalamus.  Both TRH and TSH release are under negative feedback of free T3 and 
T4. (Pic.2)
Hypothyroidism
Hypothyroidism  is  a  clinical  syndrome  caused  by  decreased  level  of  thyroid 
hormones. It can be primary in which there is intrinsic disorder of thyroid gland or it 
may be secondary in which there is pituitary or hypothalamic defect.
             Florid hypothyroidism can be diagnosed clinically.   The  symptoms  of 
hypothyroidism in descending order of frequency are:
 Tiredness, weakness
 Dry Skin
 Feeling Cold
 Hair Loss
 Difficulty in concentrating and poor memory
 Constipation
 Weight gain with poor appetite
 Dyspnea
 Hoarseness of voice
 Menorrhagia (Later amenorrhea)
 Paraesthesia
 Impaired hearing
The signs of hypothyroidism in descending order of frequency are as follows:
 Dry coarse skin
 Cool peripheral extremities
 Puffy face, hands and feet (myxedema)
 Diffuse alopecia
 Bradycardia
 Peripheral edema
 Delayed  relaxation of ankle jerk 
 Carpal tunnel syndrome
 Serous cavity effusions
In biochemical studies, TSH is the single most important parameter for screening 
hypothyroidism.  A  normal  TSH  level  rules  out  primary  hypothyroidism  but  not 
secondary.  To diagnose primary hypothyroidism TSH level should be above 20 μIU/ml 
or at least above 10 μIU/ml if clinical features strongly suggest.
In the presence of elevated TSH, low T4 especially free T4 is necessary to confirm 
hypothyroidism.  Circulating free T3 is usually reduced.  But it may be normal in 25% of 
hypothyroid  patients.   So,  T3 measurements  are  not  reliable  indicators  of 
hypothyroidism.
Hyperthyroidism
Hyperthyroidism is a clinical syndrome which results from exposure of the body 
tissues to excess circulating levels of free thyroid hormones.
The  symptoms  of  hyperthyroidism  in  descending  order  of  frequency  are  as 
follows.
 Hyper activity, irritability 
 Heat intolerance and sweating 
 Palpitations
 Fatigue and weakness
 Weight Loss with increased appetite
 Diarrhoea
 Oligomenorrhea, loss of libido
         The signs of hyperthyroidism in descending order of frequency are as follows:-
 Tachycardia. atrial fibrillation 
 Tremor
 Goiter
 Warm, moist skin
 Muscle weakness, proximal myopathy
 Lid retraction or lag
 Gynaecomastia
Laboratory investigation shows TSH below normal level.  Free and total thyroid 
hormone levels are increased.
In  2  to  5%  of  patients,  only  T3 is  increased,  a  condition  called  “T3 
thyrotoxicosis”. Occasionally, total and free T4 will be increased with normal T3  level. 
This condition is called “T4 thyrotoxicosis”.
NON THYROIDAL ILLNESS6,9,23,40,48,53
Alteration  in  serum thyroid  hormone  occurs  in  wide  variety  of  illness  which 
predominantly  affect  the  T3 level  in  whom no intrinsic  diseases  of  thyroid gland is 
detected.   It  was  variously  termed  as  “Low  T3 syndrome”,  “Sick  euthyroid 
syndrome”,  “Non  thyroid  illness  syndrome”  and  “Thyroid  hormone  adaptation 
syndrome”.
This syndrome occurs in wide variety of illness as follows.
i. Acute critical illness and febrile illness such as infection, myocardial infarction, 
etc.,
ii. Injuries such as burns, trauma, etc.,
iii. Surgery
iv. Fasting
v. Diabetes Mellitus
vi. Liver disease
vii. Renal disease
viii. Ketogenic diet
ix. Drugs such as Glucocorticoids, dopamine, phenytoin and Beta Blocker
x. Malignancy
xi. Psychiatric illness
         In non thyroid illness state, initially there is decrease in serum T3 level, both total 
and Free T3(FT3). This is associated with increase in reverse T3(rT3).
As illness progresses, there is decrease in serum T4 also, a state called “low T3, T4 
State”.  Although total T4  level decreases, the free T4(FT4) remains normal or slightly 
reduced.  In spite of this reduced T3 and T4 level, serum TSH level remains normal or 
reduced by which it is differentiated from primary hypothyroidism.  But many studies 
have shown slight  elevation of  TSH level  in non thyroidal  illness in the absence of 
hypothyroidism7,24,29.
CHRONIC RENAL FAILURE
Pathophysiology
         The unique property of kidney is that in the presence of CRF, compensatory and 
adaptive mechanism maintain acceptable health until the GFR is above 10 to 15 ml/min 
and life sustaining renal excretory and homeostatic function continues  until the GFR is 
less than 5ml/min.
Intact nephron hypothesis
         The explanation proposed for these adaptive mechanism is that in CRF there is 
progressive  loss  of  nephrons,  so  most  of  the  nephrons  are  non  functioning.  The 
remaining few functioning nephrons tend to hypertrophy and take an increased work 
load so  that  overall  loss  of  function  is  minimized.   This  indicates  that  GFR of  the 
individual  functioning  nephrons  has  increases  above  normal,  a  state  known  as 
hyperfiltration.  This increase in single nephron GFR in functioning nephrons produce 
an increased volume of  filtrate  and their  tubules respond appropriately  by excreting 
fluids and solutes in amounts which maintain external balance.  This is due to close 
integration  of  glomerular  and  tubular  functions  called  “glomerulotubular  balance” 
preserved until  terminal  stages of CRF.   These above stated popular  explanation for 
continuing function in remaining nephrons, is the “intact – nephron hypothesis”.
Trade Off Hypothesis
         It is described that adaptation arising in CRF may control one abnormality, but 
only in such a way as to produce other changes characteristic of uraemic syndrome.  The 
mechanism involved is unknown.  This trade off hypothesis is described in hormones 
like parathormone, vasopressin and ANP, solutes like sodium, potassium, phosphate and 
others.
Uraemic Syndrome
         Uraemic syndrome is a consequence of combination of the effects of the retention 
of waste products in all organ system and the failure of both endocrine and homeostatic 
function of kidney.  
The potential toxic substances that accumulate include purine metabolites amines 
indoles, phenols, myoinositl and acid polyols.
“Middle molecules” are nitrogenous substances of molecular weight between 50 
and 5000 da.  They are also suspected of contributing to uraemia.
Electrolyte and metabolic changes 
Hyperkalemia  usually  develops  when  GFR  falls  to  less  than  20-25  mL/min 
because of the decreased ability of the kidneys to excrete potassium. It can be observed 
sooner in patients who ingest a potassium-rich diet or if serum aldosterone levels are 
low, such as in type IV renal tubular acidosis, hyperkalemia in CKD can be aggravated 
by an extracellular shift of potassium, such as that occurs in the setting of acidemia or 
from lack of insulin.
Metabolic  acidosis  often  is  mixed,  non–anion  gap  and  anion  gap,  the  latter 
observed generally with CKD stage 5 but with the anion gap generally not higher than 
20 mEq/L. In CKD, the kidneys are unable to produce enough ammonia in the proximal 
tubules to excrete the endogenous acid into the urine in the form of ammonium. In CKD 
stage 5, accumulation of phosphates, sulphates, and other organic anions are the cause of 
the small anion gap. 
Extracellular  volume  expansion  and  total-body  volume  overload  results  from 
failure of sodium and free water excretion. This generally becomes clinically manifest 
when  GFR falls  to  less  than  10-15  mL/min,  when  compensatory  mechanisms  have 
become exhausted. Patients present with peripheral and, not uncommonly, pulmonary 
edema and hypertension. At a higher GFR, excess sodium and water intake could result 
in a similar picture if the ingested amounts of sodium and water exceed the available 
potential for compensatory excretion. 
Hematological changes
Normochromic  normocytic  anemia  principally  develops  from  decreased  renal 
synthesis of erythropoietin, the hormone responsible for bone marrow stimulation for 
red  blood  cell  (RBC)  production.  It  becomes  more  severe  as  GFR  progressively 
decreases  with  the  availability  of  less  viable  renal  mass.  No  reticulocyte  response 
occurs.  RBC  survival  is  decreased  and  tendency  of  bleeding  is  increased  from the 
uremia-induced platelet dysfunction
Bone changes
Secondary  hyperparathyroidism  develops  because  of  hypocalcemia,  decreased 
renal  synthesis  of  1,25-dihydroxycholecalciferol  (1,25-dihydroxyvitamin  D,  or 
calcitriol), and hyperphosphatemia.
If serum levels of PTH remain elevated, a high–bone turnover lesion, known as 
osteitis fibrosa cystica develops. This is known as renal osteodystrophy. These lesions 
develop  in  patients  with  severe  CKD  and  are  common  in  those  with  ESRD. 
Osteomalacia  and  adynamic  bone  disease  are  the  two  other  lesions  observed.  The 
former, observed primarily from aluminum accumulation, is markedly less common than 
the latter, whose etiology is unclear. Adynamic bone disease represents the predominant 
bone lesion in patients on chronic peritoneal  dialysis and is increasing in frequency. 
Dialysis-related  amyloidosis  from beta2-microglobulin  accumulation  in  patients  who 
have required chronic dialysis for at least 8-10 years is another form of bone disease that 
manifests with cysts at the ends of long bones.
OTHER CHANGES
* Pericarditis - Can complicate with cardiac tamponade, possibly resulting in death.
* Encephalopathy - Can progress to coma and death.
* Peripheral neuropathy.
* Restless leg syndrome.
* GI symptoms - Anorexia, nausea, vomiting, diarrhea.
* Skin manifestations - Dry skin, pruritus, ecchymosis.
* Fatigue, increased somnolence, failure to thrive. 
* Malnutrition.
* Erectile dysfunction, decreased libido, amenorrhea .
* Platelet dysfunction with tendency to bleeding.
Chronic renal failure as non thyroidal illness
Chronic renal failure is one among the condition causing low T3 syndrome. These 
are the some of the condition having low T3 syndrome.
TABLE  - B
CHANGES IN SERUM THYROID HORMONES AND TSH CONCENTRATION 
IN PATIENTS WITH NON THYROIDAL ILLNESS
Conditions Serum 
T3
Seru
m 
rT3
Serum 
T4
Serum 
Free T4
Serum 
TSH
Fasting ↓ ↑ = = ↓
Mild illness ↓ ↑ = =, ↑ =
Critical illness ↓ ↑ ↓ =, ↓ ↓
Surgical trauma, burns ↓ ↑ ↓ ↓ =, ↓
Chronic renal failure ↓ = =, ↓ =, ↓ =, ↓
Hepatitis =, ↑ =,  ↑ =, ↑ =, ↓ =
HIV infection = ↓ = =, ↓ =, ↑
Depression =, ↓ =, ↑ =, ↑ =, ↑ =, ↓
=  No change, ↓ Decreased, ↑ Increased
         Chronic renal failure has been divided into five stages based on the endogenous 
Creatinine clearance. A typical patient with chronic progressive renal diseases may be 
considered to pass through all 5 stages.
Stage - I :  (Decreased renal reserve)
         Endogenous Creatinine clearance is more than 90 ml/min. 
Stage - II : (Mild renal insufficiency)
         Creatinine clearance is 60-89 ml/min.  Serum Creatinine range from 2-4 mg/dl. 
Symptoms of mild azotemia, inability to concentrate urine, leading to polyuria and 
hypovolemia may be the presenting features.
Stage - III : (Moderate renal failure)
         Creatinine clearance is less than 30- 59ml/min. This stage may manifest with 
anaemia, hypertension, hyperphosphatemia, pruritis, poor intellectual performance and 
acidosis.
Stage - IV : (Severe renal failaure)
         Creatinine clearance is 15-29 ml/min.  Clinical manifestations are  similar to Stage 
III.
Stage - V : (End stage renal disease)
         End stage renal disease is reached at glomerular filtration rate (GFR) of  15 
ml/min. The clinical manifestations are pulmonary odema, pericarditis, hyperkalemia, 
fits and death. Usually serum creatinine is over 8 – 10 mg/dl.
As with other low T3 syndromes, CRF produces decrease in T3 when GFR falls 
below 50%.  There is marked decrease of T3 than T4 as the GFR decreases.  In ESRD, on 
average, diminished T4 is found in 29% of the patients and diminished T3 in 55% of the 
patients.
CRF as low T3 syndrome differs from other conditions causing similar illness, by 
two unique features40.
* rT3 is usually low or normal in CRF due to redistribution into the extra vascular 
compartment.
* Increased incidence of goiter is present in CRF, probably due to decreased 
clearance of iodine by the kidney.
PATHOPHYSIOLOGY OF LOW T3 SYNDROME
As stated above in CRF there is initial decrease in total T3, later T4 in spite of 
normal or low TSH. Various mechanism has been proposed for the change in Thyroid 
profile.
According to the postulates, CRF affect thyroid economy at all levels as follows. 
A. Changes in Hypothalamic – pituitary – thyroid axis
i.  Sensitivity of TSH secretion to low thyroid hormone is decreased.
ii.  Limited TSH reserve40
iii. Due to changes in thyrotrophs or to decreased TRH secretion, as manifested by 
decrease in nocturnal pulses of TSH secretion2,17,53.
iv. Tissue concentration of the hormone may be appropriate for the patient, so the 
patient is in euthyroid state40.
v. Serum FT3 and FT4 appears normal by sensitive methods3,5.
B. Changes in hormone Transport
i. Presence of protein and non protein inhibitors preventing the binding of thyroxine 
with thyroxine binding protein.  Non protein inhibitor is non esterified unsasturated 
fatty acid22,53.
ii. Acquired intrinsic structural alternation in the T4 binding site23.
iii. Decrease in concentration of thyroxine binding globulin40,53
C.  Changes in metabolism
i. Decrease in the activity of lodothyronine 5 – Deiodinase leading to low T340,53
ii. Increase in Non-deiodinative pathways of iodothyronine degradation leading to 
increased serum T3 sulphate, diiodotyrosine, triiodo thyroacetic acid and 
tetraiodothyroacetic acid40,53.
As previously stated, there is no increase in rT3 in CRF due to redistribution of rT3 
into extra vascular compartment40,53.
D. Changes in plasma membrane Transport
         T3 and T4 may enter cells not only by diffusion but also by active energy dependent 
transport across plasma membrane.
         Accumulation of the following substances prevents uptake and subsequent 
deiodination.
a. 3 – carboxy 4 – methyl 5 – propyl 2 – Furane (CMPF)
b. Indoxyl sulphate
In uraemia the action of thyroid hormones at nuclear level are not compromised. 
Recent study showed increased receptor expression to preserve tissue Euthryroidism52.  
DIAGNOSIS OF PRIMARY THYROID DISEASES IN CRF
Recent studies have shown the prevalence of hypothyroidism is increased in 
chronic renal failure, and also several clinical features of both hypothyroidism and 
chronic renal failure are similar, so differentiating both the conditions on clinical 
background is less likely.  Hence, all the CRF patients with symptoms of 
hypothyroidism should be screened for hypothyroidism.
Hypothyroidism should be diagnosed only if the following prevails.
a. Basal TSH level should be elevated more than 20 μIU/ml.
b. Both total and free T4 are distinctly low in the presence of normal TBG35.
c. Presence of anti thyroid antibodies can provide clue for hypothyroidism35.
d. rT3  is not useful because it is decreased in CRF.
Primary hyperthyroidism is very rare in CRF.  This condition is diagnosed by
a. Low serum TSH
b. High serum total and free T4 concentration.
High serum T4 with low T3 in the presence of CRF should make the possibility of 
T4 thyrotoxicosis.  This is because serum T3 level will be suppressed in low T3 syndrome 
with serum T4 unaffected53.
MANAGEMENT
Several studies have been conducted in patients with the T3 syndrome in order to 
correct the thyroid profile by treating with L-Thyroxine18 and Triiodothyronine5.
Gregory Brent et al18 conducted study in non thyroidal illness patients by treating 
all the patients with serum total T4 less than 5 μg/dl with 1.5 μg/Kg of L-thyroxine for 2 
weeks.  Thyroxine level increased significantly in treated patients.  Serum T3 levels were 
also raised.  But mortality was increased in treatment group on day 5 – 17.
Carter et al5studied effects of Triiodothyronine administration in patients with 
chronic renal failure.  Study showed serum T3 level did not change over a period of 12 
weeks.  But the mean serum T4 and TSH levels were affected significantly.  There was 
no subjective improvement in these patients.
Based on this observation, it has been suggested that low serum T3 level in 
patients with severe renal failure is metabolically protective and it is interpreted as 
physiological adaptation to reduce basal metabolic rate (BMR) and to conserve energy 
in an adverse environment.  Hence, this condition has been renamed as “Thyroid 
hormone adaptation syndrome”53.
         Administration of T4 or T3 causes suppression of TSH and increases the catabolism. 
So, administration of thyroid hormone is not beneficial.  Study also showed increased 
morality with the treatment.  Therefore, thyroid hormone should not be given in CRF 
unless true hypothyroidism can be documented.
PROGNOSIS
Magnitude of the Thyroid dysfunction that occurs in patients with chronic renal 
failure, in general, reflects the severity of the illness.  The prognosis is poor in patients 
with lower serum T3 and T4 or TSH concentration.  Studies have shown that after renal 
transplant the low T3, T4 and TSH return to normal level.
MATERIALS AND METHODS
               Patients admitted to the Nephrology ward, Coimbatore Medical College 
Hospital, Coimbatore with chronic renal failure who are on conservative management.
Study Design:
             Single Centre, Non randomized prospective study.
Study Period:
             Study was conducted between January 2007 and August 2008 for a period of 18 
months.
Sample Size:
              In the study period of 18 months among patients admitted in Nephrology ward 
after applying inclusion and exclusion criteria 50patients will be included in this study.
             Patients  who fulfill  the criteria  for  CRF and who are  on conservative 
management, Thyroid profile would be done in all patients who fulfilling the criteria. 
Informed consent was obtained from all patients.
Selection Criteria:
1. Symptoms of uraemia for 3 months or more.
2. Elevated blood urea, Serum creatinine
3. Ultrasound evidence of chronic renal failure
a. Bilateral contracted kidneys- size less than 8 cm in male and size less than 7 
cms in female
b. Poor corticomedullary differentiation
c . Type 2 or 3 renal parenchymal changes
4. Supportive laboratory evidence of CRF like anemia, urine specific gravity,changes 
in serum electrolytes, etc.,
Exclusion Criteria:
1. Patients underwent peritoneal dialysis or hemodialysis
2. Nephrotic range of proteinuria
3. Low serum protein especially albumin
4. Other conditions like
a. Acute illness
b. Recent surgery,trauma or burns
c. Diabetes mellitus
d. Liver diseases
e. Drugs altering thyroid profile like amiodarone, steroids, dopamine, phenytoin, 
oestrogen pills,iodine containing drugs.
Detailed clinical history and clinical examination was undertaken with preference 
to thyroid and renal diseases. The following investigations were performed.
1. Urine for specific gravity and broad cast
2. Peripheral smear for anaemia and burr cells.
3. Renal parameters like blood urea, Serum creatinine and Creatinine clearance 
(using Cockcroft- Gault formula)
4. Serum calcium and  phosphorus
5. Serum cholesterol for hypothyroidism
6. 24 hours urine protein and serum protein to rule out nephrotic syndrome and 
hypoproteinemia respectively
7. ECG and chest X ray to look for features for hypothyroidism and renal failure like 
pleural effusion, pericardial effusion.
8. USG abdomen for evidence of chronic renal failure
After selecting the patients, fulfilling the above criteria, about 5ml of blood sample 
is collected in non heparinised serum bottle and sent for thyroid profile.
Components of thyroid profile in this study  are serum triiodothyronine,  serum 
thyroxine, serum thyroid stimulating hormone.Quantitative determination of T3,T4,TSH 
is done by Enzyme linked Immunosorbent Assay.
RESULTS AND OBSERVATIONS
50  patients  with  CRF  who  were  on  conservative  management  were  studied. 
Among 50 patients, 10 patients were female and 40 patients were male.  The age varied 
from 12 – 70 years.   Among 50 patients,  10 patients  were 30 years  and below, 33 
patients were in the age group of 30 – 60 years and 7 patients above 60 years.
Observation regarding CRF in this study
The duration of CRF in this study varied from 3 months to 5 years.  The 
Creatinine clearance varied from 6 ml/min to 34 ml/min. 20 patients had GFR 10 ml/min 
accounting for 40%, 20 patients GFR 11 – 20 ml/min accounting for another 40%, 
remaining 10 patients accounting for 20% had GFR more than 20 ml/min.
Blood urea varied from 64 to 170 mg/dl and Creatinine varied from 3 mg to 17.2 
mg/dl.
         24 hours urinary protein excretion was less than 1 gm/day in all the patients in this 
study group.
Serum calcium and phosphorous were normal  in all  the patients.   80% of the 
patients  had  anaemia  with  peripheral  smear  revealing  normocytic  normochromic 
anaemia in 72% and hypochromic anaemia in 8% of the patients.
TABLE - 1
SERUM CONCENTRATION OF THYROID HORMONE
Thyroid 
hormones
Normal 
range
Study 
range
Mean
Std. 
Dev.
Mean 
excluding 
hypothyrodism
Std. 
Dev
Serum T3 
ng/ml
0.6 – 2.1 0.2 to 2 0.673 0.414 0.7122 0.4368
Serum T4 
μg/dl
5 – 13
0.5 to 
9.5
5.622 2.27 5.99 2.08
Serum 
TSH 
μIU/ml
0.4 – 7 0.6 to 27 6.53 6.98 4.75 4.151
TABLE - 2
DISTRIBUTION OF LOW T3 AND T4 AMONG VARIOUS
LEVELS OF TSH
TSH level μ IU/ml
No. of Patients 
with Low T3
No. of Patients 
with Low T4
< 7 16 (57.14%) 8 (53.33%)
7.1 – 20 7 (25%) 2 (13.33%)
> 20 5 (17.85%) 5 (33.33%)

TABLE - 3
ANALYSIS OF THYROID DYSFUNCTION IN THIS STUDY
Thyroid dysfunction No. of Patients Percentage
Low T3 syndrome 23 46%
Low T4 syndrome 10 20%
Hypothyroidism 5 10%

       
  Ultra sound abdomen showed evidence of CRF in all patients contracted kidney 
was present  in  90% of  the  patients.   Remaining patients  had poor  corticomedullary 
differentiation.  
         Among the 50 patients, low serum T3 level was found in 28 patients (56%), 5 
patients among the low serum T3 level also had high TSH value more than 20 μIU/ml 
with low T4 level and also symptoms suggestive of hypothyroidism.
         These patients as per the criteria were grouped under “primary hypothyroidism”. 
Remaining 6 patients had slightly elevated TSH ranging between 9 and 14 μIU/ml.  In 
these 6 patients, only 3 patients had low T3 level, among which only one patient had few 
clinical features of hypothyroidism. So, these 6 patients didn’t satisfy the criteria for 
hypothyroidism fully.  So all 23 patients were grouped under “Low T3 syndrome” of 
“sick Euthyroid syndrome”.
TABLE - 4
ANALYSIS OF SERUM T3 T4 AND TSH EXCLUDING
HYPOTHYROIDISM
Thyroid 
d
y
s
f
u
n
c
t
i
o
n
No. of 
Patients 
with 
Normal 
values
%
No. of Pt 
with low 
values
%
No. of pt 
with high 
values
%
T3 22 44% 23 46% NIL NIL
T4 35 70% 10 20% NIL NIL
TSH 38 76% NIL NIL 7 14%
TABLE - 5
AGE INCIDENCE OF LOW T3 SYNDROME IN THIS STUDY
Age in years No. of Patients Low T3 syndrome Percentage
< 30 10 3 33%
31 – 60 33 17 51.50%
> 60 7 3 42.85%

TABLE - 6
SEX INCIDENCE OF LOW T3 SYNDROME IN THIS STUDY
Sex
NO. OF 
PATIENTS
Low T3 
Syndrome
Percentage
Male 40 (80%) 20 50%
Female 10 (20%) 3 30%
Object 4
Dry,  flaky  skin  was  present  in  15  patients  of  which  only  4  patients  were 
hypothyroid.
         Sinus bradycardia was present in 7 patients.
        Hypothyroidism didn’t show any linear correlation with GFR.  Increased number of 
hypothyroid patients of about 4 in number were present in GFR 11 – 20 ml/min whereas 
only 2 patients had hypothyroidism in GFR less than 10 ml/min.
         Age comparison of Low T3 syndrome in table-5 shows about 30% of CRF patients 
below 30 years of age have low T3 syndrome.  The percentage increases to 51.51% in 
the age group 31 – 60  years.  This is probably due to increased CRF patients in this age  
group.  In age above 60 years, 42.85% have low T3 syndrome.
         Sex  incidence  in  this  study  (Table-6)  shows  50% of  males  have  low T 3 
syndromeand only 30% of the females have low T4 syndrome.
Observation of T3 in this study
         T3 level in this study varied from 0.2 to 2 ng/ml.  The mean value of T3 is 0.67 
ng/ml (Table-1).  Excluding the patients with primary hypothyroidism, the mean value is 
0.71 ng/ml.  This value was in low normal limit.  Excluding hypothyroidism T3 levels 
were studied in relation to GFR.  It was found that mean value of serum T3 is low (0.538 
ng/ml) only in patients with GFR less than 10 ml/min (Table – 10).  The mean value is 
low normal in patients with GFR more than 10 ml/min.  According to the study, number 
of patients with low T3 increase with increase in severity of the renal failure (Table-8) in 
spite of low T3 levels.  
Observations of T4 in the study
         Serum T4 level in the study varies from 0.5 to 9.5 μg/dl. Mean value of serum T4 
among 50 patients 5.62 μg/dl Excluding hypothyroid patients, the mean value is 5.99 
μg/dl.  This value is within low normal level of T4.  
TABLE - 8
DISTRIBUTION OF LOW T3 AND T4 SYNDROME IN THIS STUDY
Creatinine 
Clear
ance 
ml/mi
n
Low T3 Syndrome Low T4 Syndrome
No. of 
Patient
Percentage
No. of 
Percentage
< 10 13 65% 6 30%
11 – 20 7 35% 3 15%
> 20 5 30% 1 10%

TABLE - 9
DISTRIBUTION OF THYROID DYSFUNCTION IN THIS STUDY AMONG 
VARIOUS CREATININE CLEARANCE LEVELS
Creatinine Clearance 
ml/min
No. of 
Patients
Low T3 
Syndrome
Hypothyroidism
< 10 20 (40%) 13 (65%) 3 (15%)
11 – 20 20 (40%) 7 (35%) 2 (10%)
> 20 10 (20%) 3 (30%) NIL
TABLE - 10
CORRELATION OF THYROID HORMONES WITH SEVERITY OF RENAL 
FAILURE EXCLUDING HYPOTHYROIDISM
Creatinine 
Cle
ara
nce 
ml/
mi
n
Mean T3 
μg/dl
Std. 
Dev
Mean T4 
μg/dl
Std. 
Dev.
Mean TSH 
μIU/ml
Std. 
Dev
< 10 (n=17) 0.538 0.40 5.02 2.10 5.22 4.25
11 – 20 (n=18) 0.82 0.43 6.69 2.17 3.77 3.78
> 20 0.8 0.31 6.32 2.04 5.72 5.00
            Excluding 5 hypothyroidism patients who have low T4 values, 9 (21.33%) other 
patients had T4 level below normal and low T3 syndrome.
         Number of patients with low T4 does not correlate with severity of renal disease  
(Table 8).  The mean value of T4 excluding hypothyroidism patients was normal at all 
the stages of renal failure (Table 9).  
        None of the patients had T4 value above normal level.
Observation of TSH in the study
         Values of TSH vary from 0.6 to 27 μIU/ml with mean value in 6.53 μIU/ml.  
Object 6
Excluding hypothyroidism mean value is 4.75 μIU/ml.  This shows normal serum level 
of TSH.
         Among the 50 patients, TSH was normal in 38 patients (76%) and values between  
7.1 – 20 μIU/ml in 7 patients (14%).  It was elevated more  than 20 μIU/ml in 5 patients  
(10%).
         According to our study, in patients with low T3 syndrome, the mean values of TSH 
in various stages of renal failure are within normal range.  But the values of TSH didn’t 
show any linear correlation with GFR.
DISCUSSION
Thyroid dysfunction in CRF was extensively studied by Ramirez37.
part from his study, various studies conducted in this line have showed different 
results.
In this study, patients only on conservative management were studied.  This is 
because thyroid profile undergoes changes due to dialysis independent of that due to 
chronic renal failure.  Dialysis also changes the previous serum status of thyroid 
hormone in the patients with renal failure. Many studies have conducted by comparing 
CRF patients conservative Management and Hemodialysis by Ramirez42 and kayima et 
al29.
         Many studies conducted in CRF patients showed low T3 values.  Low T3 had been 
reported in Ramirez et al37, Hegedus et al21, Beckett et al37,21,2 studies, that to in severe 
renal failure.  Ramirez and spectar et al37 study showed linear correlation between the 
mean serum T3 and T4 and severity of renal failure.
         As with other studies, mean T3 level in our study was reduced below normal in 
GFR less than 10 ml/min.  In higher GFR, it was present in low normal and there was no 
linear correlation between T3 level and GRF which is consistent with Avasthi et al 
study1.
         Mean T4 level in this study is within normal limits in all levels of GFR, but it is in 
low normal level and also it does not correlate with the severity of renal failure.
         In this study, not all the patients with CRF have low T3 and T4.  It is estimated that 
only 58% (29 patients) of patients have Thyroid Profile abnormality.  Remaining 42% of 
patients have normal thyroid profile.
         Among 58% of these patients exclude primary hypothyroid patients 28% have only 
low T3 level with normal T4 level.  Remaining 20% have both low T3 and T4 level. The 
percentage of patients having low T3 and T4 gradually increase, with decrease in GFR. 
The patient who will develop such change in thyroid profile is not known.
         Excluding hypothyroidism, mean TSH level in our study is within normal limits. 
The mean TSH levels are also within normal limits for the various ranges of GFR.  But 
TSH level doesn’t show any linear correlation with the severity of renal failure.  This is 
consistent with the study conducted by Spector and Ramirez et al49,37.  These studies 
demonstrated abnormality in hypophyseal mechanism of TSH release in uraemic 
patients as the as the TSH response to the TRH was blunted.
         Other studies conducted by Joseph et al and Hardy et al24,19 revealed low T3 T4 
level with high TSH level suggesting maintenance of pituitary thyroid axis.
         In this study, excluding those with hypothyroidism, seven patients had mild 
elevation of TSH with low T3 level.  Among these patients, T4 is within normal limits in 
4 of the patients.  In the remaining 3 patients T4 is below normal.  There were no clinical 
features suggestive of hypothyroidism in these patients.  Investigations like FT4,  FT3 
TRH response and anti thyroid auto antibodies can be done to diagnose hypothyroidism 
in these patients.
         Out study is consistent with the results of Ramirez et al37 study showing low T3, 
low T4 and normal or mild elevation of TSH. Yet it is unclear that to what extent these 
changes are responsible for the manifestations of Uraemic syndrome.  From the various 
studies it has been suggested that this thyroid profile derangements is a part of body 
adaptation mechanism.
Dialysis
         As stated previously, Hemodialysis and continuous ambulatory peritoneal dialysis 
have shown to affect the thyroid profile independently of CRF.  Also drugs like heparin, 
furosemide used during dialysis will affect the thyroid profile.
         Kayima et al29 and Giordano et al16 have conducted studies regarding effect of 
dialysis on CRF patients with thyroid dysfunction.  These study showed no significant 
improvement in thyroid profile after repeated hemodialysis.
         But in the patients who have undergone renal transplant surgery, most of the 
thyroid function parameters returned to normal with TSH below normal55.
Hypothyroidism
         Previous studies by Quion verde et al36 reported high prevalence of 
hypothyroidism in CRF.  It was estimated to be about 5% in patients with terminal renal 
failure.
Detail study by Kaptein et al25,26 estimated the prevalence of primary 
hypothyroidism was about 2.5 times much frequent in chronic renal failure and dialysis. 
The hypothyroidism in CRF was estimated to range between 0 and 9.5% Kaptein study 
also estimated the presence of anti thyroid antibody titer in 6.7% of CRF.  
In our study, the hypothyroidism is present in 10% of the patients but doesn’t 
correlate with the severity of the renal failure.  The symptoms of hypothyroidism were 
distributed equally in both hypothyroid and CRF patients in our study.  Signs of 
hypothyroidism were more common in CRF without hypothyroidism  than with 
hypothyroidism.
So, diagnosis of hypothyroidism in CRF mainly rest on TSH level which should 
be very  high (> 20 MIU/dl) with low serum T4.
         In this study no patient had clinical or biochemical features of hyperthyroidism.
         
CONCLUSIONS
1. Thyroid hormone dysfunction occurs in 58% of the chronic renal failure patients.
2. Incidence of hypothyroidism is increased in patients with chronic renal failure.
3. Both clinical and biochemical parameters are essential to diagnose hypothyroidism 
in patients with CRF.
4. Excluding patients with hypothyroidism, T3 level is low in 46% of the patients, T4 
level is low in 20% of the patients.
5. Number of patients with low T3 and T4 syndrome progressively increase with 
severity of renal failure.
6 Serum level of T3 and T4 has no correlation with the severity of renal failure.
7. Alteration in the values of T3 and T4 occurs as a part of body adaptations 
mechanism to conserve energy.
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PROFORMA
Name: Age:     Sex: I.P.No:
Occupation: Address:
Past history:
HT: Y/N DM: Y/N Recent Surgery: Y/N
Drugs:Y/N Jaundice:Y/N
Other Systemic illness:Y/N
Menstrual and Obstetrical History:
General Examination:
1. Nourishment:
2. Pallor:
3. Hyper pigmentation:
4. Facial Puffiness:
5. Pedal edema:
6. Skin texture:
7. Thyroid swelling:
8. Vital signs:
Pulse: B.P:
Respiratory Rate: Temperature:
C.V.S.:
R.S.:
Abdomen:
C.N.S.:
Investigations:
1. Urine complete examination:
2. 24 hrs Urine Protein:
3. Blood:
Hb: gm/dl
Tc:
DC:
RBC:
Peripheral Smear:
4. Blood
Urea: Creatinine:
Serum electrolytes: Na:           K:
Calcium: Phosphorus:
Serum Cholesterol: Serum Proteins
5. ECG:
6. Chest X- Ray
7. USG Abdomen
8. Thyroid  Profile:
Serum triidodothyroxine:
Serum Thyroxine
Serum thyroid stimulating hormone
ABBREVIATIONS
CKD - Chronic Kidney Disease
DIT - Diiodotyrosine 
ESRD - End stage renal disease
FT4 - Free Thyroxine
GFR - Glomerular Filtration Rate
MIT - Monoiodotyrosine
PTH - Parathyroid hormone
T3 - Triiodothyronine
T4 - Thyroxine
TRH - Thyrotropin Releasing Hormone
TSH - Thyroid Stimulating Hormone 
TBG - Thyroxine Binding Globulin 
